Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Completed				Not specified				Other				MBG308 NCT00126412


2.		131MIBG to Treat Malignant Pheochromocytoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 70				Other				020032 02-CH-0032, NCT00028106

Last Modified: 7/19/2007 First Published: 2/10/2006


3.		Phase II Study of Iodine I 131 Metaiodobenzylguanidine as Palliative Therapy in Patients With Refractory or Relapsed Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 1				NCI				UCSF-05161 UCSF-00161, NCT00013806

Last Modified: 2/23/2006 First Published: 7/1/2000


4.		Phase I Study of Iodine I 131 Metaiodobenzylguanidine Plus Intensive Chemotherapy Followed By Autologous Hematopoietic Stem Cell Transplantation in Patients With Refractory or Residual High-Risk Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				1 to 21 (1 to 20 at diagnosis)				NCI				NANT-99-01 CHLA-LA-NANT-99-01, NCI-V00-1592, NCT00005978

Last Modified: 6/5/2006 First Published: 4/23/2004


5.		Phase I Study of Iodine I 131 Metaiodobenzylguanidine (131I-MIBG) Double Infusion Followed By Autologous Hematopoietic Stem Cell Transplantation in Patients With Refractory Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				1 to 30				NCI				NANT-2000-01 NCT00083135


6.		ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				MIP-IB11 NCT00339131

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute